Influence of CsA therapy on the outcome of kidneys with anatomic anomalies.
Berardinelli
L
L
Division of Vascular Surgery and Kidney Transplantation, Policlinico University Hospital, IRCCS, Milan, Italy.
Carini
M
M
Beretta
C
C
Vegeto
A
A
D000714:Anastomosis, Surgical; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007668:Kidney / Q000002:abnormalities*; D016030:Kidney Transplantation / Q000379:methods* / Q000401:mortality / Q000502:physiology; D012077:Renal Artery / Q000002:abnormalities* / Q000601:surgery; D012189:Retrospective Studies; D015996:Survival Rate; D014019:Tissue Donors; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine